Table 2 The lifetime risk of CVD up to age 95 adjusted for the competing risk of death for men and women at age 35, 45 and 55 according to individual fasting blood glucose variability (CV)
FBG variability category (CV, %) | Total | Men | Women | ||||||
|---|---|---|---|---|---|---|---|---|---|
No. of CVD case/total | Lifetime risk% (95%CI) | P-value | No. of CVD case/total | Lifetime risk% (95%CI) | P-value | No. of CVD case/total | Lifetime risk% (95%CI) | P-value | |
35Â years | |||||||||
 Low (< 6.19) | 528/15339 | 26.3 (23.0, 29.5) | Ref | 455/11262 | 28.0 (24.5, 31.4) | Ref | 73/4077 | 17.8 (11.3, 24.2) | Ref |
 Intermediate (6.19–10.86) | 603/15340 | 28.3 (25.5, 31.1) | 0.357 | 547/11676 | 30.8 (27.9, 33.8) | 0.214 | 56/3664 | 13.8 (9.6, 18.1) | 0.316 |
 High (> 10.86) | 758/15339 | 32.5 (28.9, 36.1) | 0.013 | 688/12124 | 34.7 (30.9, 38.5) | 0.010 | 70/3215 | 18.1 (10.6, 25.7) | 0.942 |
45Â years | |||||||||
 Low (< 6.26) | 502/12713 | 26.0 (22.8, 29.3) | Ref | 430/9519 | 27.5 (24.1, 31.0) | Ref | 72/3194 | 17.9 (11.5, 24.2) | Ref |
 Intermediate (6.26%-11.03%) | 584/12720 | 27.7 (25.0, 30.5) | 0.443 | 528/9755 | 30.1 (27.2, 33.1) | 0.269 | 56/2965 | 14.1 (9.9, 18.4) | 0.335 |
 High (> 11.03%) | 704/12716 | 32.1 (28.3, 35.9) | 0.018 | 638/10042 | 34.4 (30.5, 38.4) | 0.011 | 66/2674 | 18.0 (9.4, 26.5) | 0.990 |
55Â years | |||||||||
 Low (< 6.57%) | 345/7041 | 24.6 (21.3, 28.0) | Ref | 294/5533 | 25.9 (22.3, 29.5) | Ref | 51/1508 | 16.4 (10.2, 22.5) | Ref |
 Intermediate (6.57–11.40) | 408/7042 | 25.6 (22.8, 28.4) | 0.655 | 364/5505 | 27.6 (24.5, 30.7) | 0.468 | 44/1537 | 13.5 (9.1, 18.0) | 0.464 |
 High (> 11.40) | 468/7041 | 30.4 (26.3, 34.5) | 0.032 | 423/5532 | 32.5 (28.2, 36.8) | 0.020 | 45/1509 | 16.8 (7.8, 25.8) | 0.937 |